Cece Jr., Cesar L.

HRN: 24-02-82  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2023
CEFTRIAXONE 1G (VIAL)
11/07/2023
11/14/2023
IV
2g
Q24
UTI
Waiting Final Action 
11/10/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/10/2023
11/16/2023
IVT
500mg
Q8
T/c Hepatoma
Waiting Final Action 
12/07/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/07/2023
12/14/2023
IVT
500mg
Q8
Hepatoma
Waiting Final Action 
12/07/2023
CEFTAZIDIME 1GM (VIAL)
12/07/2023
12/14/2023
IVT
1g
Q8
Hepatoma
Waiting Final Action 
12/11/2023
METRONIDAZOLE 500MG (TAB)
12/11/2023
12/17/2023
ORAL
500mg
QID
Hepatoma
Waiting Final Action 
12/14/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/14/2023
12/20/2023
IV
4.5gm
Q8
Intraabdominal Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: